← FDA Drug Approvals (Drugs@FDA)

EMPAGLIFLOZIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LAURUS GENERICS INC · Approved 2022-06-30

Drug application

FDA Application #

ANDA212421

Application type

Abbreviated New Drug Application (Generic)

Brand name

EMPAGLIFLOZIN

Generic name

Empagliflozin

Active ingredients

EMPAGLIFLOZIN

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

LAURUS GENERICS INC

First approval

2022-06-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown